These findings, along with the role of YAP1 in neoangiogenesis, opens new avenues to combat various cancers which are driven by YAP1, as well as tumors like RCC, which show loss of VHL along with elevated YAP1 levels. Here, VHL is linked to renal cell carcinoma.